In this Q&A, Mwango Kashoki, MD, MPH, SVP and global head of regulatory strategy at Parexel, breaks down the FDA's plausible ...

The Drugs Consultative Committee (DCC), during its 68th meeting, deliberated on strengthening regulatory oversight and ...

Greater transparency in FDA decision-making was possibly the most common theme for stakeholders interviewed by the Institute ...

As laws expand around the world, physicians, philosophers and families are confronting difficult questions about suffering ...

Advance care planning (ACP) is a critical way to align patients' goals and values with their medical care. These ...

What do you think are the two biggest issues facing your district? How would you address them in Congress? The nation is ...

2025 marked another great year for movies, joining the ranks of what will be the very best films of the decade, at least ...

Want to learn more about our closest relatives in the animal kingdom? That would have to be apes, with humans and apes ...

In short, times have changed – and something else seems to have shifted too: the previous overwhelming reverence for the ANC ...

S&P 500 looks stretched with narrow leadership—pullback risk rising. Learn key risks, focus on sustained trends, and adopt a ...

Good day, and welcome to the RTX First Quarter 2026 Earnings Conference Call. My name is Latif, and I will be your operator for today. As a reminder, this conference is being recorded for replay ...